Immuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid Tumours

NCT05638334 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Sponsor decision

Conditions

Advanced Solid Tumor

Interventions

DRUG: 89Zr-S095012 tracer and S095012 will be administered via an IV infusion

Sponsor

Institut de Recherches Internationales Servier

Collaborators

[object Object]